Cell-mediated immunotherapies have potential as adjuvant and stand-alone therapies for cancer. antigen publicity, and utilizes a story autophagy-mediated system to assist in display. Treatment with this liposome outcomes in a significant decrease of growth development using an intense LLC1 model in vaccinated C57BD/6 rodents. These data offer proof-of-principle for a story cell-mediated immunotherapy that is… Continue reading Cell-mediated immunotherapies have potential as adjuvant and stand-alone therapies for cancer.